RI
WST icon

Rudd International’s West Pharmaceutical WST Stock Holding History

Rudd International’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$268K Buy
+1,180
New +$232K 0.14% 59

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

Rudd International's WST Position: Q2 2020 in Review

Rudd International opened a new position in West Pharmaceutical (WST) in Q2 2020: 1,180 shares worth $268K. The stake represents 0.14% of the portfolio and ranks #59 among its holdings.

523 funds tracked by Wall St. Rank hold WST as of Q2 2020.

  • Rudd International held 1,180 shares of West Pharmaceutical worth $268K as of Q2 2020.
  • West Pharmaceutical was a new Rudd International position in Q2 2020.
  • West Pharmaceutical made up 0.14% of Rudd International's portfolio in Q2 2020, its #59 holding.
  • 523 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2020.

Based on Rudd International's 13F filing for Q2 2020, filed 4 Aug 2020.